Epi-Ivermectine B1a

Epi-Ivermectin B1a is a key related substance of Ivermectin , primarily existing as a process-related impurity or potential degradation product in ivermectin-based antiparasitic formulations. epi-Ivermectin B1a can be used for the study of internal/external parasites in cattle[1].

2962875-16-5

22,23-Dihydro avermectin B1a; epi-Dihydro avermectin B1a

12352005

Parasite

Anti-infection

COVID-19-immunoregulation

Infection

C/C([C@H]([C@H](/C=C/C=C1CO[C@]([H])([C@@H](C(C)=C[C@@]2(C3=O)[H])O)[C@@]\12O)C)O[C@]4(C[C@@H]([C@H]([C@@H](O4)C)O[C@@]5(O[C@H]([C@@H]([C@H](C5)OC)O)C)[H])OC)[H])=C\C[C@@]6(C[C@@]([H])(C[C@@]7(O6)CC[C@@H]([C@]([H])(O7)[C@@H](C)CC)C)O3)[H]

C48H74O14

875.09

[1]Padivitage N, et al. Simultaneous determination of ivermectin, clorsulon and their related substances in an injectable finished product by a stability-indicating RP-HPLC method. J Pharm Biomed Anal. 2022 Feb 20;210:114580.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W765152/

Natural Products

No Development Reported